CGTs promise to revolutionize treatment for diseases like cancer and hereditary conditions but face adoption barriers. High costs, complex logistics, and reimbursement uncertainties are major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback